Cargando…
A Fermented Wheat Germ Extract Contains Protein Components Active against NSCLC Xenografts In Vivo
Non-small cell lung cancer (NSCLC) continues to be the leading cause of cancer-related deaths. Although advances have been made in the past decade to treat such tumors, most options induce multiple side effects, and many patients discontinue therapy due to toxicity. Thus, the need remains for non-to...
Autores principales: | Levis, Daniel J., Meckler, Joshua F., O’Donnell, Robert T., Tuscano, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530145/ https://www.ncbi.nlm.nih.gov/pubmed/37754232 http://dx.doi.org/10.3390/cimb45090448 |
Ejemplares similares
-
A Novel bispecific T-cell engager (BiTE) targeting CD22 and CD3 has both in vitro and in vivo activity and synergizes with blinatumomab in an acute lymphoblastic leukemia (ALL) tumor model
por: Meckler, Joshua F., et al.
Publicado: (2023) -
Fermented wheat germ extract - nutritional supplement or anticancer drug?
por: Mueller, Thomas, et al.
Publicado: (2011) -
Anti-Oxidant and Anti-Adipogenic Effects of Ethanol Extracts from Wheat Germ and Wheat Germ Fermented with Aspergillus oryzae
por: Park, Euna, et al.
Publicado: (2015) -
Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
por: Otto, Christoph, et al.
Publicado: (2016) -
Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin’s lymphoma
por: Kato, Jason, et al.
Publicado: (2012)